Marion Bosc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marion Bosc has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Philippe De Deurwaerdère
University of Bordeaux, France; Centre National de la Recherche Scientifique (CNRS), unit 5287, Institut des Neurosciences Intégratives et Cognitives d'Aquitaine (INCIA), Bordeaux, France
3 shared publications - Adam Kepecs
Department of Neuroscience and Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA
2 shared publications - Benjamin Dehay
Univ. de Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, France
2 shared publications Bernard Bioulac
Univ. Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, France
2 shared publications- Katharina Schmack
Francis Crick Institute, London, UK
2 shared publications - Thomas Michelet
Univ. Bordeaux, CNRS, INCIA, UMR 5287, F-33000 Bordeaux, France
2 shared publications
Latest Publications
- 2 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Du doute à la vérification : étude comportementale et électrophysiologique de la prise de décision chez le primate non-humain
La vérification est un comportement volontaire mis en place à la suite d’un doute ou de la détection d’une erreur au cours d’une prise de décision. De très rares études se sont intéressées aux bases physiologiques de ce comportement, la majorité des travaux étant basés sur l’analyse des comportements pathologiques, comme les vérifications associées au trouble obsessionnel compulsif. Ces travaux de thèse ont consisté à déterminer les bases neurobiologiques du comportement de vérification chez le primate non-humain, un modèle de choix dans l’étude de la physiopathologie humaine. Pour cela deux singes macaque rhésus ont été entrainés à la tâche « Check-or-Go » permettant aux sujets de vérifier et éventuellement modifier la disponibilité d’une récompense avant de confirmer la décision afin d’accéder à cette même récompense. A l’aide d’une analyse comportementale, de dosages d’un biomarqueur de l’anxiété, d’enregistrements EEG du cortex préfrontal et d’enregistrements extracellulaires unitaires au niveau de CMAr et pré-SMA, nous avons pu montrer que : (i) les singes ont les capacités métacognitives d’exprimer un comportement volontaire de vérification similaire à celui observé chez l’Homme, (ii) ce comportement est sous tendu par l’émergence du doute, (iii) est corrélé au niveau d’anxiété, et (iv) est associé à des mécanismes cognitifs mettant en jeu le cortex préfrontal, et plus spécifiquement CMAr et pré-SMA.
- 2 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Du doute à la vérification : étude comportementale et électrophysiologique de la prise de décision chez le primate non-humain
La vérification est un comportement volontaire mis en place à la suite d’un doute ou de la détection d’une erreur au cours d’une prise de décision. De très rares études se sont intéressées aux bases physiologiques de ce comportement, la majorité des travaux étant basés sur l’analyse des comportements pathologiques, comme les vérifications associées au trouble obsessionnel compulsif. Ces travaux de thèse ont consisté à déterminer les bases neurobiologiques du comportement de vérification chez le primate non-humain, un modèle de choix dans l’étude de la physiopathologie humaine. Pour cela deux singes macaque rhésus ont été entrainés à la tâche « Check-or-Go » permettant aux sujets de vérifier et éventuellement modifier la disponibilité d’une récompense avant de confirmer la décision afin d’accéder à cette même récompense. A l’aide d’une analyse comportementale, de dosages d’un biomarqueur de l’anxiété, d’enregistrements EEG du cortex préfrontal et d’enregistrements extracellulaires unitaires au niveau de CMAr et pré-SMA, nous avons pu montrer que : (i) les singes ont les capacités métacognitives d’exprimer un comportement volontaire de vérification similaire à celui observé chez l’Homme, (ii) ce comportement est sous tendu par l’émergence du doute, (iii) est corrélé au niveau d’anxiété, et (iv) est associé à des mécanismes cognitifs mettant en jeu le cortex préfrontal, et plus spécifiquement CMAr et pré-SMA.
- Open Access
The antipsychotic drug clozapine suppresses autoimmunity driving psychosis-like behavior in mice
Antipsychotic drugs are the first-line treatment for psychosis yet their mechanism of action remains poorly understood, largely due to the challenge to faithfully model psychosis preclinically. Here, we focus on the emerging concept that psychosis can be caused by brain autoimmunity and present a novel mouse model of anti-N-methyl-D-aspartate-receptor (anti-NMDAR) encephalitis, a condition that manifests with psychosis and autoantibodies against the NMDAR. We devised a new mRNA-based approach to immunize mice against the NMDAR. Immunized mice developed psychosis-like behaviors that were caused by anti-NMDAR autoantibodies leading to phagocytosis of NMDARs by brain micro-glia. The antipsychotic drug clozapine rescued psychosis-like behaviors and, remarkably, reduced anti-NMDAR autoantibody levels and antibody-mediated phagocytosis of NMDARs. The immunomodulato-ry effects of clozapine were confirmed in a mouse model of systemic lupus erythematosus. Our results demonstrate that clozapine suppresses autoimmunity driving psychosis-like behaviors, raising the possibility that immunomodulation contributes to antipsychotic drug action.
Open AccessThe antipsychotic drug clozapine suppresses autoimmunity driving psychosis-like behavior in mice
Antipsychotic drugs are the first-line treatment for psychosis yet their mechanism of action remains poorly understood, largely due to the challenge to faithfully model psychosis preclinically. Here, we focus on the emerging concept that psychosis can be caused by brain autoimmunity and present a novel mouse model of anti-N-methyl-D-aspartate-receptor (anti-NMDAR) encephalitis, a condition that manifests with psychosis and autoantibodies against the NMDAR. We devised a new mRNA-based approach to immunize mice against the NMDAR. Immunized mice developed psychosis-like behaviors that were caused by anti-NMDAR autoantibodies leading to phagocytosis of NMDARs by brain micro-glia. The antipsychotic drug clozapine rescued psychosis-like behaviors and, remarkably, reduced anti-NMDAR autoantibody levels and antibody-mediated phagocytosis of NMDARs. The immunomodulato-ry effects of clozapine were confirmed in a mouse model of systemic lupus erythematosus. Our results demonstrate that clozapine suppresses autoimmunity driving psychosis-like behaviors, raising the possibility that immunomodulation contributes to antipsychotic drug action.
- Open Access
Bounded optimality of time investments in rats, mice, and humans
Time is our scarcest resource. Allocating time optimally presents a universal challenge for all organisms because the future benefits of time investments are uncertain. We developed a normative framework for assessing bounded optimality in time allocation, emphasizing the accuracy of future predictions, independent of subjective costs and benefits. In a common decision task across humans, rats, and mice, we varied uncertainty by titrating ambiguous sensory evidence and measured the time each subject was willing to invest post-decision. We observed that all species and subjects invested more time when they were more likely to be correct, which reflected a statistical confidence of uncertain evidence. Time allocation strategy approached the lower bound of optimality, indicating an accurate decision-by-decision assessment of confidence in the likelihood that waiting will pay off – independent of the subjective payoff values and time costs. We demonstrate that an elementary algorithm based on a drift-diffusion process algorithm can implement this optimal time investment strategy. These results illuminate the computational mechanisms governing rational time investment, showing that humans, rats, and mice can maximize payoffs via confidence-guided time allocation. Highlights Computational and behavioral framework to assess bounded optimality of investments. Humans, rats, and mice invest more time to obtain more likely payoffs, in proportion to statistical confidence. Time investment was close to optimal model predictions, reflecting bounded optimality of investments under uncertainty. Bounded-optimal time investment may be an evolutionary ancient adaptive behavioral strategy.
Open AccessBounded optimality of time investments in rats, mice, and humans
Time is our scarcest resource. Allocating time optimally presents a universal challenge for all organisms because the future benefits of time investments are uncertain. We developed a normative framework for assessing bounded optimality in time allocation, emphasizing the accuracy of future predictions, independent of subjective costs and benefits. In a common decision task across humans, rats, and mice, we varied uncertainty by titrating ambiguous sensory evidence and measured the time each subject was willing to invest post-decision. We observed that all species and subjects invested more time when they were more likely to be correct, which reflected a statistical confidence of uncertain evidence. Time allocation strategy approached the lower bound of optimality, indicating an accurate decision-by-decision assessment of confidence in the likelihood that waiting will pay off – independent of the subjective payoff values and time costs. We demonstrate that an elementary algorithm based on a drift-diffusion process algorithm can implement this optimal time investment strategy. These results illuminate the computational mechanisms governing rational time investment, showing that humans, rats, and mice can maximize payoffs via confidence-guided time allocation. Highlights Computational and behavioral framework to assess bounded optimality of investments. Humans, rats, and mice invest more time to obtain more likely payoffs, in proportion to statistical confidence. Time investment was close to optimal model predictions, reflecting bounded optimality of investments under uncertainty. Bounded-optimal time investment may be an evolutionary ancient adaptive behavioral strategy.
- 27 May 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 92 (9) , 722-729
Check or Go? Impact of Doubt on the Hierarchical Organization of the Mediofrontal Area
- 27 May 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 92 (9) , 722-729
Check or Go? Impact of Doubt on the Hierarchical Organization of the Mediofrontal Area
- 1 November 2021
- Published by Elsevier in Neurobiology of Aging
- Vol. 107, 53-56
Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairment
- 1 November 2021
- Published by Elsevier in Neurobiology of Aging
- Vol. 107, 53-56
Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairment
- Top Cited Papers
- 2 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 372 (6537) , 51-+
Striatal dopamine mediates hallucination-like perception in mice
How to model hallucinations in mice: There has not been enough progress in our understanding of the basic mechanisms underlying psychosis. Studying psychotic disorders in animal models is difficult because the diagnosis relies on self-reported symptoms that can only be assessed in humans. Schmack et al. developed a paradigm to probe and rigorously measure experimentally controlled hallucinations in rodents (see the Perspective by Matamales). Using dopamine-sensor measurements and circuit and pharmacological manipulations, they demonstrated a brain circuit link between excessive dopamine and hallucination-like experience. This could potentially be useful as a translational model of common psychotic symptoms described in various psychiatric disorders. It may also help in the development of new therapeutic approaches based on anatomically selective modulation of dopamine function. Science , this issue p. eabf4740 ; see also p. 33
- 2 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 372 (6537) , 51-+
Top Cited PapersStriatal dopamine mediates hallucination-like perception in mice
How to model hallucinations in mice: There has not been enough progress in our understanding of the basic mechanisms underlying psychosis. Studying psychotic disorders in animal models is difficult because the diagnosis relies on self-reported symptoms that can only be assessed in humans. Schmack et al. developed a paradigm to probe and rigorously measure experimentally controlled hallucinations in rodents (see the Perspective by Matamales). Using dopamine-sensor measurements and circuit and pharmacological manipulations, they demonstrated a brain circuit link between excessive dopamine and hallucination-like experience. This could potentially be useful as a translational model of common psychotic symptoms described in various psychiatric disorders. It may also help in the development of new therapeutic approaches based on anatomically selective modulation of dopamine function. Science , this issue p. eabf4740 ; see also p. 33
- 15 November 2017
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 24 (8) , 741-744
Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation?
- 15 November 2017
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 24 (8) , 741-744
Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation?
- Open Access
- 28 March 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep45267
Checking behavior in rhesus monkeys is related to anxiety and frontal activity
When facing doubt, humans can go back over a performed action in order to optimize subsequent performance. The present study aimed to establish and characterize physiological doubt and checking behavior in non-human primates (NHP). We trained two rhesus monkeys (Macaca mulatta) in a newly designed “Check-or-Go” task that allows the animal to repeatedly check and change the availability of a reward before making the final decision towards obtaining that reward. By manipulating the ambiguity of a visual cue in which the reward status is embedded, we successfully modulated animal certainty and created doubt that led the animals to check. This voluntary checking behavior was further characterized by making EEG recordings and measuring correlated changes in salivary cortisol. Our data show that monkeys have the metacognitive ability to express voluntary checking behavior similar to that observed in humans, which depends on uncertainty monitoring, relates to anxiety and involves brain frontal areas.
- 28 March 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep45267
Open AccessChecking behavior in rhesus monkeys is related to anxiety and frontal activity
When facing doubt, humans can go back over a performed action in order to optimize subsequent performance. The present study aimed to establish and characterize physiological doubt and checking behavior in non-human primates (NHP). We trained two rhesus monkeys (Macaca mulatta) in a newly designed “Check-or-Go” task that allows the animal to repeatedly check and change the availability of a reward before making the final decision towards obtaining that reward. By manipulating the ambiguity of a visual cue in which the reward status is embedded, we successfully modulated animal certainty and created doubt that led the animals to check. This voluntary checking behavior was further characterized by making EEG recordings and measuring correlated changes in salivary cortisol. Our data show that monkeys have the metacognitive ability to express voluntary checking behavior similar to that observed in humans, which depends on uncertainty monitoring, relates to anxiety and involves brain frontal areas.
- 25 April 2013
- Published by Springer Nature in Experimental Brain Research
- Vol. 230 (4) , 477-511
Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology
Serotonin2C (5-HT2C) receptors are expressed in the basal ganglia, a group of subcortical structures involved in the control of motor behaviour, mood and cognition. These receptors are mediating the effects of 5-HT throughout different brain areas via projections originating from midbrain raphe nuclei. A growing interest has been focusing on the function of 5-HT2C receptors in the basal ganglia because they may be involved in various diseases of basal ganglia function notably those associated with chronic impairment of dopaminergic transmission. 5-HT2C receptors act on numerous types of neurons in the basal ganglia, including dopaminergic, GABAergic, glutamatergic or cholinergic cells. Perhaps inherent to their peculiar molecular properties, the modality of controls exerted by 5-HT2C receptors over these cell populations can be phasic, tonic (dependent on the 5-HT tone) or constitutive (a spontaneous activity without the presence of the ligand). These controls are functionally organized in the basal ganglia: they are mainly localized in the input structures and preferentially distributed in the limbic/associative territories of the basal ganglia. The nature of these controls is modified in neuropsychiatric conditions such as Parkinson’s disease, tardive dyskinesia or addiction. Most of the available data indicate that the function of 5-HT2C receptor is enhanced in cases of chronic alterations of dopamine neurotransmission. The review illustrates that 5-HT2C receptors play a role in maintaining continuous controls over the basal ganglia via multiple diverse actions. We will discuss their interest for treatments aimed at ameliorating current pharmacotherapies in schizophrenia, Parkinson’s disease or drugs abuse.
- 25 April 2013
- Published by Springer Nature in Experimental Brain Research
- Vol. 230 (4) , 477-511
Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology
Serotonin2C (5-HT2C) receptors are expressed in the basal ganglia, a group of subcortical structures involved in the control of motor behaviour, mood and cognition. These receptors are mediating the effects of 5-HT throughout different brain areas via projections originating from midbrain raphe nuclei. A growing interest has been focusing on the function of 5-HT2C receptors in the basal ganglia because they may be involved in various diseases of basal ganglia function notably those associated with chronic impairment of dopaminergic transmission. 5-HT2C receptors act on numerous types of neurons in the basal ganglia, including dopaminergic, GABAergic, glutamatergic or cholinergic cells. Perhaps inherent to their peculiar molecular properties, the modality of controls exerted by 5-HT2C receptors over these cell populations can be phasic, tonic (dependent on the 5-HT tone) or constitutive (a spontaneous activity without the presence of the ligand). These controls are functionally organized in the basal ganglia: they are mainly localized in the input structures and preferentially distributed in the limbic/associative territories of the basal ganglia. The nature of these controls is modified in neuropsychiatric conditions such as Parkinson’s disease, tardive dyskinesia or addiction. Most of the available data indicate that the function of 5-HT2C receptor is enhanced in cases of chronic alterations of dopamine neurotransmission. The review illustrates that 5-HT2C receptors play a role in maintaining continuous controls over the basal ganglia via multiple diverse actions. We will discuss their interest for treatments aimed at ameliorating current pharmacotherapies in schizophrenia, Parkinson’s disease or drugs abuse.
- Open Access
- 1 March 2013
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 11 (2) , 160-170
Serotonin2C Receptors and the Motor Control of Oral Activity
Data from many experiments has shown that serotonin2C (5-HT2C) receptor plays a role in the control of orofacial activity in rodents. Purposeless oral movements can be elicited either by agonists or inverse agonists implying a tight control exerted by the receptor upon oral activity. The effects of agonists has been related to an action of these drugs in the subthalamic nucleus and the striatum, the two input structures for cortical efferents to the basal ganglia, a group of subcortical structures involved in the control of motor behaviors. The oral effects of agonists are dramatically enhanced in case of chronic blockade of central dopaminergic transmission induced by neuroleptics or massive destruction of dopamine neurons. The mechanisms involved in the hypersensitized oral responses to 5-HT2C agonists are not clear and deserve additional studies. Indeed, while the oral behavior triggered by 5-HT2C drugs would barely correspond to the dyskinesia observed in humans, the clinical data have consistently postulated that 5-HT2C receptors could be involved in these aberrant motor manifestations.
- 1 March 2013
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 11 (2) , 160-170
Open AccessSerotonin2C Receptors and the Motor Control of Oral Activity
Data from many experiments has shown that serotonin2C (5-HT2C) receptor plays a role in the control of orofacial activity in rodents. Purposeless oral movements can be elicited either by agonists or inverse agonists implying a tight control exerted by the receptor upon oral activity. The effects of agonists has been related to an action of these drugs in the subthalamic nucleus and the striatum, the two input structures for cortical efferents to the basal ganglia, a group of subcortical structures involved in the control of motor behaviors. The oral effects of agonists are dramatically enhanced in case of chronic blockade of central dopaminergic transmission induced by neuroleptics or massive destruction of dopamine neurons. The mechanisms involved in the hypersensitized oral responses to 5-HT2C agonists are not clear and deserve additional studies. Indeed, while the oral behavior triggered by 5-HT2C drugs would barely correspond to the dyskinesia observed in humans, the clinical data have consistently postulated that 5-HT2C receptors could be involved in these aberrant motor manifestations.